Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
In the never-ending quest to discover previously unknown CRISPR gene-editing systems, researchers have scoured microbes in everything from hot springs and peat bogs to poo and even yogurt. Now, thanks ...
A screening approach has been designed to measure efficiency and specificity for thousands of CRISPR-associated transposons ...
The model is built on CRISPR technology, a powerful gene editing tool used to edit genomes and develop therapies for genetic diseases. However, training to use this tool for designing experiments can ...
News-Medical.Net on MSN
New screening method boosts efficiency and accuracy of CAST genome editing
Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes.
Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology. The study by researchers at ...
Scribe highlights latest data on Lp(a)-lowering therapy and novel AI platform for next-generation CRISPR-based therapeutics at two premier conferences ...
The study combines a deep learning model with CRISPR screens to control the expression of human genes in different ways -- such as flicking a light switch to shut them off completely or by using a ...
Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
About SRSD107 SRSD107 is a novel double-stranded small interfering ribonucleic acid (siRNA), that is designed to target the human coagulation factor XI (FXI) mRNA and inhibit FXI protein expression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback